1990
DOI: 10.1159/000216738
|View full text |Cite
|
Sign up to set email alerts
|

Preoperative Immunostimulation with Propionibacterium avidum KP-40 in Patients with Gastric Carcinoma: A Prospective Randomized Study

Abstract: Sixty-eight patients admitted for resection of gastric carcinoma entered a prospectively randomized trial. Patients in the therapy group (n = 34) received a preoperative controlled infusion of 10 mg Propionibacterium avidum KP-40. The therapy and control group did not differ with regard to postoperative complications, tumor recurrence rates (therapy group: 41%, control group: 38%), and patient survival rates (survival rate in the therapy group after 25 months: 53%, in the control group after 25 months: 50%).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1992
1992
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…According to in vitro and in vivo model results obtained during the early 1990s, the Pulverer group in Germany decided to move from the bench to the bedside with prospective randomized studies including patients with gastrointestinal tumors (212). No effect was observed regarding postoperative complications or tumor recurrence rates between the control and treatment groups (212), but after a preoperative intravenous (i.v.) infusion of 10 mg of the whole C. avidum KP-40 preparation, they demonstrated enhanced neopterin secretion in urine, with persistence of this biomarker.…”
Section: Antitumor Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…According to in vitro and in vivo model results obtained during the early 1990s, the Pulverer group in Germany decided to move from the bench to the bedside with prospective randomized studies including patients with gastrointestinal tumors (212). No effect was observed regarding postoperative complications or tumor recurrence rates between the control and treatment groups (212), but after a preoperative intravenous (i.v.) infusion of 10 mg of the whole C. avidum KP-40 preparation, they demonstrated enhanced neopterin secretion in urine, with persistence of this biomarker.…”
Section: Antitumor Activitymentioning
confidence: 99%
“…infusion of 10 mg of the whole C. avidum KP-40 preparation, they demonstrated enhanced neopterin secretion in urine, with persistence of this biomarker. Indeed, neopterin is considered to be an early signal of the cellular immune response (126). They also highlighted that only a lymphocyte subset population (the natural killer cell population) was statistically increased following infusion of the same preparation (same dose) (110,111).…”
Section: Antitumor Activitymentioning
confidence: 99%